We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.92B
AUM Growth
-$118M
Cap. Flow
-$387M
Cap. Flow %
-5.59%
Top 10 Hldgs %
73.6%
Holding
128
New
2
Increased
25
Reduced
68
Closed
5

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$13.6M
2
C icon
Citigroup
C
+$10.3M
3
ECL icon
Ecolab
ECL
+$9.75M
4
AMZN icon
Amazon
AMZN
+$8.59M
5
HD icon
Home Depot
HD
+$8.35M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$300M
2
META icon
Meta Platforms (Facebook)
META
+$53.9M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$42.9M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.5M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.74M

Sector Composition

Rank Sector Weight
1 Financials 30.75%
2 Consumer Discretionary 19.53%
3 Communication Services 15.03%
4 Healthcare 13.85%
5 Materials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$165B
$25.2M 0.36%
351,908
-3,955,127
-92% -$300M
PFE icon
27
Pfizer
PFE
$143B
$19.9M 0.29%
579,045
– –
AMGN icon
28
Amgen
AMGN
$209B
$19.3M 0.28%
110,716
– –
CELG
29
DELISTED
Celgene Corp
CELG
$18.6M 0.27%
177,762
-1,257
-0.7% -$142K
AGN
30
DELISTED
Allergan plc
AGN
$15.6M 0.22%
95,086
– –
DVAX
31
DELISTED
Dynavax Technologies
DVAX
$14.4M 0.21%
770,441
-53,384
-6% -$1.07M
ABBV icon
32
AbbVie
ABBV
$465B
$13.9M 0.2%
143,271
– –
SHPG
33
DELISTED
Shire pic
SHPG
$13.5M 0.2%
87,322
+18,103
+26% +$2.68M
VTRS icon
34
Viatris
VTRS
$20.8B
$13.4M 0.19%
316,045
+129,506
+69% +$4.95M
BMY icon
35
Bristol-Myers Squibb
BMY
$129B
$13.1M 0.19%
213,452
-43,579
-17% -$2.73M
BIIB icon
36
Biogen
BIIB
$30.9B
$13.1M 0.19%
40,974
-8,691
-17% -$2.79M
INSM icon
37
Insmed
INSM
$22.4B
$12.2M 0.18%
392,007
-55,422
-12% -$1.64M
CI icon
38
Cigna
CI
$78.4B
$11.9M 0.17%
58,777
– –
CLVS
39
DELISTED
Clovis Oncology, Inc.
CLVS
$11.5M 0.17%
169,700
-40,927
-19% -$2.86M
HCA icon
40
HCA Healthcare
HCA
$90.6B
$11.5M 0.17%
130,618
– –
MRK icon
41
Merck
MRK
$322B
$11.3M 0.16%
210,456
– –
ESRX
42
DELISTED
Express Scripts Holding Company
ESRX
$11.2M 0.16%
150,710
+36,442
+32% +$2.33M
PRTK
43
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$11M 0.16%
614,900
-30,200
-5% -$630K
EXEL icon
44
Exelixis
EXEL
$13.9B
$10.7M 0.15%
352,508
+67,920
+24% +$1.81M
LLY icon
45
Eli Lilly
LLY
$1.08T
$10.6M 0.15%
125,120
– –
EW icon
46
Edwards Lifesciences
EW
$49.4B
$10.4M 0.15%
277,179
– –
CNC icon
47
Centene
CNC
$30.5B
$9.45M 0.14%
187,306
– –
BSX icon
48
Boston Scientific
BSX
$68.4B
$9.1M 0.13%
367,194
– –
ALXN
49
DELISTED
Alexion Pharmaceuticals
ALXN
$9.05M 0.13%
75,704
-6,240
-8% -$760K
GKOS icon
50
Glaukos
GKOS
$9.49B
$7.53M 0.11%
293,360
+1,935
+0.7% +$57.6K
1
2
3 4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2017 Portfolio in Review

As of Q4 2017, C WorldWide Group held 128 positions worth $6.92B, down 1.7% from $7.04B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

C WorldWide Group withdrew a net $387M in Q4 2017, closing 5 positions and reducing 68 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $5.74M position sold in full.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, C WorldWide Group opened a new position in Pinnacle Foods, Inc. worth $1.02M.

  • C WorldWide Group's largest Q4 2017 buy was Pinnacle Foods, Inc.: 17,200 shares worth $1.02M.
  • C WorldWide Group added most to Visa in Q4 2017, an estimated $13.6M increase.
  • C WorldWide Group's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $300M.
  • C WorldWide Group fully exited Teva Pharmaceuticals in Q4 2017, selling an estimated $5.74M.
  • C WorldWide Group's ten largest holdings make up 74% of its $6.92B portfolio in Q4 2017.
  • C WorldWide Group opened 2 new positions and closed 5 in Q4 2017.
  • C WorldWide Group's portfolio value fell 1.7% quarter-over-quarter to $6.92B.

Based on C WorldWide Group's 13F filing for Q4 2017, filed 7 Feb 2018.